PEDIATRIC ONCOLOGY GROUP

儿科癌症合作小组的概念是在 30年前，由于儿科恶性疾病的罕见性， 对照试验对改善此类患者的结局至关重要， 患者 要使这样一个团体取得成功， 来自各种专业和研究领域的个人是 绝对必要 这种多模式的治疗方法 儿童癌症的合作小组已经很好地证明了其 值 贝勒医学院儿科血液肿瘤科 医学参与了这类临床研究的起源 并参加了各个层次的活动。 预计 这种情况将在下一个补助期继续下去并有所增加。 初步调查正在进行中，希望能提供 未来儿科肿瘤学小组工作的背景。

The concept of the pediatric cooperative cancer group was introduced over 30 years ago, because of the rarity of pediatric malignant diseases and the vital importance of controlled trials to improve the outcome for such patients. For such a group to succeed, the collaborative contributions of individuals from a large variety of specialties and fields of research are absolutely essential. This multimodal organized approach to the treatment of childhood cancer through the cooperative group has well-demonstrated its value. The Section of Pediatric Hematology-Oncology at Baylor College of Medicine has been involved in the genesis of this kind of clinical research and has participated in the activities at every level. It is anticipated that this will continue and increase during the next grant period. Preliminary investigators are ongoing which hopefully will provide background for future Pediatric Oncology Group efforts.